Kraig Biocraft Laboratories, Inc. (KBLB) › Cash & EquivalentsKraig Biocraft Laboratories, Inc. (KBLB) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2010-12-31: $92.2K2011-12-31: $195.4K2012-12-31: $53.8K2013-12-31: $295.4K2014-12-31: $495.0K2015-12-31: $238.2K2016-12-31: $298.9K2017-12-31: $18.1K2018-12-31: $13.7K2022-12-31: $3.86M2023-12-31: $2.55M2024-12-31: $673.3K2025-12-31: $1.79M$1.79M2010-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$1.79M+165.9%2026-03-30Balance as of period end2024-12-31$673.3K-73.6%2026-03-30Balance as of period end2023-12-31$2.55M-33.9%2025-03-28Balance as of period end2022-12-31$3.86M—2024-04-01Balance as of period end2018-12-31$13.7K-24.5%2019-03-29Balance as of period end2017-12-31$18.1K-93.9%2019-03-29Balance as of period end2016-12-31$298.9K+25.5%2018-03-23Balance as of period end2015-12-31$238.2K-51.9%2017-03-22Balance as of period end2014-12-31$495.0K+67.6%2016-03-30Balance as of period end2013-12-31$295.4K+449.2%2015-03-31Balance as of period end2012-12-31$53.8K-72.5%2014-04-15Balance as of period end2011-12-31$195.4K+111.8%2013-12-24Balance as of period end2010-12-31$92.2K—2012-04-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)